References
- Leysen J E, Awouters F, Kennis L, Laduron P M, Vandenberk J, Janssen P AJ. Receptor binding profile of R41468 a novel antagonist at 5HT2 receptors. Life Sci 1981; 28: 1015–1022
- Wenting G J, Man in't, Veld A J, Woittiez A J, Boomsma F, Schalekamp M ADH. Treatment of hypertension with ketanserin a new selective 5HT2 receptor antagonist. Br Med J 1982; 284: 537–539
- Anderson A, Morgan T, Dumpys R. The effect of ketanserin in essential hypertension. Clin Exp Pharmacol Physiol 1983; 10: 331–333
- Persson B, Hedner T, Henning M. Cardiovascular effects in the rat of ketanserin a novel 5-hydroxytryptamine receptor blocking agent. J Pharm Pharmacol 1982; 34: 442–445
- Vanhoutte P M, van Nueten J M, Symoens J, Janssen P A.J. Antihypertensive properties of ketanserin (R41468). Fed Proc 1983; 42: 182–185
- Reimann I W, Frolich J C. Mechanism of antihypertensive action of ketanserin in man. Br Med J 1983; 287: 381–383
- Bulpitt C J, Dollery C T. Side effects of hypotensive agents evaluated by a self-administered questionnaire. Br Med J 1973; 3: 485–490
- Bonnin J M, Cain M D, Jose J S, Mukherjee T M, Perrett L V, Scroop G C, Seymour A E. Hypertension due to renin-secreting tumour localised by segmental renal sampling. Aust NZ J Med 1977; 7: 630–635
- Ogihara T, Iinuma K, Nishi K, Arakawa Y, Takagi A, Kurata K, Miyai K, Kumahara Y. A non-chromatographic non-extraction radioimmunoassay for serum aldosterone. J Clin Endocr Metab 1977; 45: 726–731
- Hills M, Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmac 1979; 8: 7–20
- Bulpitt C J, Dollery C T, Carne S. Change in symptoms of hypertensive patients after referral to hospital clinic. Brit Heart J 1976; 28: 121–128
- Dollery C T, Davies D S, Draffen G H, Dargie H J, Dean C R, Reid J L, Clare R A, Murray S. Clinical pharmacology and pharmacokinetics of clonidine. Clin Pharm Ther 1976; 19: 11–17
- Degli Uberti E C, Transforini G, Margutti A R, Rotola C A, Pansini R. Effect of ketanserin, a new inhibitor of 5HT2 receptors, on plasma renin activity and aldosterone levels in normal subjects. Horm Res 1982; 16: 244–248
- Wing L MH, West M J, Graham J R, Chalmers J P. Long-acting and short-acting diuretics in mild essential hypertension. Clin Exp Hyper 1982; 4: 1429–1441